Your blog category
Baltimore, MD – December 13, 2025 Auxergen is excited to announce the publication of summer intern Desmond L. Seybold’s first-author paper in International Journal of Molecular Science. Desmond is an undergraduate at the University of Maryland, Baltimore County, and joined us through the IMET Undergraduate Summer Internship Program. Culminating in research conducted over the Summer…
Baltimore, MD – January 22, 2026 Auxergen is proud to announce its latest publication in Virology, led by first author Vincent Tsai. Currently a senior at Wego High School, Vincent Tsai is the first high school student to serve as the lead author of any study published in the journal’s history since founding in 1955….
Baltimore, MD – September 5, 2025 Auxergen, a leading multinational biotechnology company specializing in virology and microbial genomics, announced its participation in the 2025 American Society for Virology (ASV) annual meeting held in Montreal, Canada, from July 14 to 17. The company’s scientific team was selected to deliver three poster presentations, highlighting innovative research in…
Baltimore, Maryland – April 4, 2025 Auxergen announces the establishment of its new, production-capable, state-of-the-art biotech laboratory at the Institute of Marine and Environmental Technology (IMET), marking a significant step almost five years to the day since installing at the Harbor Launch Incubator at IMET on April 11, 2020. The new facilities will enable Auxergen…
Baltimore, Maryland – January 24, 2025 Auxergen has been named one of the top eight “Companies to Watch” in Baltimore for 2025 by the Baltimore Business Journal, a publication reaching over 2.3 million readers annually. This recognition coincides with the fifth anniversary of Auxergen’s incorporation at the Institute of Marine and Environmental Technology (IMET) on…
Baltimore, Maryland – November 5, 2024 Auxergen’s latest research on the rapidly evolving mpox strains has been published in The Lancet Microbe. With a ranking of 2nd out of 132 in the infectious disease category, and 3rd out of 161 in the microbiology category, it is one of the world’s foremost scientific journals. Key Findings:…
Baltimore, Maryland – November 3, 2024 Unlocking the Secrets of Virus Assembly: A Breakthrough at Auxergen Exciting News! Auxergen has just published groundbreaking research in the journal Virology, revealing the secrets of virus assembly. Our study on Xanthomonas integrative filamentous phages uncovers novel packaging mechanisms that could revolutionize disease treatments and biotechnological solutions. Key Findings:…
Baltimore, Maryland – July 3, 2024 Auxergen announces the establishment of an Italian division to bring the Auxergen’s Xylella treatment to Italy and the wider E.U. Learn more at the Baltimore Business Journal Media Contact: Michael Feehley michael@auxergen.com 443.929.9757
Rome, Italy – May 20, 2024 Today, Auxergen had a productive meeting with Coldiretti leadership to discuss our groundbreaking bacteriophage solution, designed to combat Olive Quick Decline Syndrome (OQDS). Coldiretti, the leading agricultural business association in Italy with over 1.6 million members, is a champion of sustainable agriculture and food systems. Their commitment to supporting…
San Diego, California – March 18, 2024 Auxergen Inc., an innovator in biotechnology based in Maryland, proudly announces its selection for a coveted presentation slot at the esteemed BIO International Convention 2024, happening from June 3-6 at the San Diego Convention Center. This event, known as the world’s largest gathering for the biotechnology industry, brings together…